rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2007-4-5
|
pubmed:abstractText |
The serotonin and norepinephrine transporter inhibitor sibutramine is a widely used antiobesity drug. In acute studies, the peripheral sympathomimetic effect of sibutramine was counteracted by a central sympatholytic action.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0021-972X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
92
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1560-3
|
pubmed:meshHeading |
pubmed-meshheading:17284621-Adult,
pubmed-meshheading:17284621-Appetite Depressants,
pubmed-meshheading:17284621-Blood Pressure,
pubmed-meshheading:17284621-Body Mass Index,
pubmed-meshheading:17284621-Body Weight,
pubmed-meshheading:17284621-Cyclobutanes,
pubmed-meshheading:17284621-Female,
pubmed-meshheading:17284621-Humans,
pubmed-meshheading:17284621-Male,
pubmed-meshheading:17284621-Obesity,
pubmed-meshheading:17284621-Regression Analysis,
pubmed-meshheading:17284621-Weight Loss
|
pubmed:year |
2007
|
pubmed:articleTitle |
Sympathetic vasomotor tone determines blood pressure response to long-term sibutramine treatment.
|
pubmed:affiliation |
Franz-Volhard Clinical Research Center, Medical Faculty of the Charité and HELIOS Klinikum, Berlin, Germany.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|